Stockreport

Zevra Stock Surges Close to 70% in 3 Months: Here's Why [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF ZVRA obtained FDA approval for arimoclomol capsules for the treatment of Niemann-Pick disease type C (NPC) in September. The drug will be marketed under the brand name M [Read more]